Working on my annual #biopharma and #medtech “Winners & Losers” presentation for the Genesis 2024 conference. Happy to receive nominations for entry into the list - list them here or send to [email protected]
Just to let my followers here know, like many others, I will be transitioning to Blue Sky - my handle will be @BioPharmaMike.bsky.social #biotech #biopharma #medtech
I have 2 new followers from Iceland, and more last week. See fedica.com/!BioPharmaMike
Will be moderating a panel discussion at @OneNucleus #Genesis conference looking at the anatomy of a star #biopharma #dealmaker. Interested in hearing from here what are the key attributes required? #biotech #pharma
Excited to share, this year’s @Clarivate Drugs to Watch report is the winner ow.ly/8Xg550PIXIA of TWO 2023 #DataComms Awards -- GOLD in the Best Data Insight from an Integrated Campaign category and BRONZE in the Most Innovative Use of Data category!
Special thank you to my 4 new followers from South Africa, and more last week. fedica.com/!BioPharmaMike
Pleased to take part in latest episode of the #BioWorld Insider Podcast, alongside BioWorld managing editor Karen Carey to talk about #biopharma deal making, M&A and financing trends in 1H 2023 plus how U.K. firms faring post #Brexit Download from here: lnkd.in/gMGeJHdT
The @WHO global research agenda for antimicrobial resistance #AMR in human health prioritizes 40 R&D topics to generate new evidence to inform AMR policies and interventions by 2030. Available here: lnkd.in/ej9tNbXh. #WHO #AMRResearchAgenda #Launch
I have 3 new followers from Azerbaijan, and more last week. See fedica.com/!BioPharmaMike
Replying to @BioWorld
@BioWorld brings together leaders of preclinical companies for hot topics discussion at #BIO2023 @DTxPharma @Combined_Tx @kytopen @LynnYoffee @elevationonc @BioPharmaMike @russopartners
Mike Ward retweeted
Replying to @BioWorld
@BioWorld brings together leaders of preclinical companies for hot topics discussion at #BIO2023 @DTxPharma @Combined_Tx @kytopen @LynnYoffee @elevationonc @BioPharmaMike @russopartners
Mike Ward retweeted
Coming up on June 15, a webinar hosted by @BioPharmaMike of @Clarivate will feature ACMA CEO William Soliman, Ph.D., for a conversation on the impact of biologics and biosimilars on the US Market.
Register here: hubs.ly/Q01SvnBT0
Heading off to Boston for @IAmBiotech BBIO2023. Looking forward to chairing an insightful panel on #biotech partnerships in #oncology, with execs from @pfizer, @takeda & @VolastraTx. Also explore @ClarivateHealth innovative solutions at Booth #1965: ow.ly/vBvY50OvcVL
Life science research has accelerated over the past few decades, especially with challenge of #COVID. @Clarivate experts Jonathan Adams and David Pendlebury from the #ISI discuss how scientific #research is evolving in the US. Listen at ow.ly/ECJc50OAUxX.
#pharma #biotech
Mike Ward retweeted
Exciting news! Join us at #BIO2023 by @IAmBiotech for an insightful panel on #biotech partnerships in #oncology, moderated by @BioPharmaMike. Plus, explore our innovative solutions at Booth #1965: ow.ly/vBvY50OvcVL
Looking forward to what looks like a very cool event in London on 21st June - the World Without Disease Summit - stellar speaker line up worldwithoutdisease.com/
Since 2017, Mainland China has greatly expanded availability of novel drugs through regulatory reforms, bringing greater access from domestic and international manufacturers alike. Read our latest blog here: ow.ly/QbsT50OtujO
#oncology #rarediseases #pharma #MainlandChina











